Literature DB >> 8434653

Visceral glomerular epithelial cells can proliferate in vivo and synthesize platelet-derived growth factor B-chain.

J Floege1, R J Johnson, C E Alpers, S Fatemi-Nainie, C A Richardson, K Gordon, W G Couser.   

Abstract

In glomerular diseases associated with antibody- and complement-mediated injury to endothelial and mesangial cells, cell proliferation is an important early response that precedes matrix accumulation and glomerulosclerosis. In contrast, in diseases in which the visceral glomerular epithelial cell (vGEC) is the principal target of injury, cell proliferation is not a recognized consequence, although vGECs respond in vitro to a variety of growth factors and inflammatory mediators. To explore the possibility that low levels of vGEC proliferation may occur and participate in such diseases, serial studies were done in the passive Heymann nephritis model of membranous nephropathy, in which the vGEC is the primary target of antibody- and C5b-9-mediated injury. The results showed mitotic figures and positive staining for the proliferating cell nuclear antigen in cells whose location defined them as vGECs. The proliferating cell nuclear antigen-positive cells at the edge of the capillary wall were confirmed to be vGECs by double-immunostaining with antibodies to SPARC/osteonectin, which preferentially label vGECs in passive Heymann nephritis. Proliferation of vGECs in vivo was preceded by increased glomerular expression of platelet-derived growth factor (PDGF) B-chain protein and messenger RNA, both of which localized to vGECs. PDGF B-chain protein and messenger RNA were also detected in cultured vGECs. PDGF receptor beta-subunit protein or messenger RNA could not be demonstrated in vGECs in vivo or in vitro, and no growth response of cultured vGECs to PDGF was noted. These results suggest that proliferation of vGECs does occur in a model of glomerular injury induced by antibody and C5b-9 on vGECs. VGEC proliferation and production of PDGF may be involved in the restoration of the capillary wall but could also contribute to local capillary wall injury and proliferation of other cells in Bowman's capsule, interstitium, and tubules.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8434653      PMCID: PMC1886749     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  64 in total

Review 1.  Pathogenesis of membranous nephropathy.

Authors:  W G Couser; C K Abrass
Journal:  Annu Rev Med       Date:  1988       Impact factor: 13.739

2.  Identification of a major sialoprotein in the glycocalyx of human visceral glomerular epithelial cells.

Authors:  D Kerjaschki; H Poczewski; G Dekan; R Horvat; E Balzar; N Kraft; R C Atkins
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

3.  Enhanced glomerular prostaglandin formation in experimental membranous nephropathy.

Authors:  R A Stahl; S Adler; P J Baker; Y P Chen; P M Pritzl; W G Couser
Journal:  Kidney Int       Date:  1987-05       Impact factor: 10.612

4.  Anti-Fx1A produces complement-dependent cytotoxicity of glomerular epithelial cells.

Authors:  R J Quigg; A V Cybulsky; J B Jacobs; D J Salant
Journal:  Kidney Int       Date:  1988-07       Impact factor: 10.612

5.  Rat glomerular cells do not express podocytic markers when cultured in vitro.

Authors:  H Holthöfer; K Sainio; A Miettinen
Journal:  Lab Invest       Date:  1991-11       Impact factor: 5.662

6.  Activation of glomerular mesangial cells by the terminal membrane attack complex of complement.

Authors:  D H Lovett; G M Haensch; M Goppelt; K Resch; D Gemsa
Journal:  J Immunol       Date:  1987-04-15       Impact factor: 5.422

7.  Evidence suggesting a role for hydroxyl radical in passive Heymann nephritis in rats.

Authors:  S V Shah
Journal:  Am J Physiol       Date:  1988-03

8.  Morphologic correlates of glomerular oxidant injury induced by the myeloperoxidase-hydrogen peroxide-halide system of the neutrophil.

Authors:  R J Johnson; S J Guggenheim; S J Klebanoff; R F Ochi; A Wass; P Baker; M Schulze; W G Couser
Journal:  Lab Invest       Date:  1988-03       Impact factor: 5.662

9.  Expression of proliferating cell nuclear antigen (PCNA)/cyclin during the cell cycle.

Authors:  P Kurki; M Vanderlaan; F Dolbeare; J Gray; E M Tan
Journal:  Exp Cell Res       Date:  1986-09       Impact factor: 3.905

10.  The complement membrane attack complex stimulates the prostanoid production of cultured glomerular epithelial cells.

Authors:  G M Hänsch; M Betz; J Günther; K O Rother; B Sterzel
Journal:  Int Arch Allergy Appl Immunol       Date:  1988
View more
  16 in total

Review 1.  Experimental membranous nephropathy redux.

Authors:  Andrey V Cybulsky; Richard J Quigg; David J Salant
Journal:  Am J Physiol Renal Physiol       Date:  2005-10

2.  Complement C5b-9 induces receptor tyrosine kinase transactivation in glomerular epithelial cells.

Authors:  A V Cybulsky; T Takano; J Papillon; A J McTavish
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

3.  Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephropathy.

Authors:  J Floege; W Kriz; M Schulze; M Susani; D Kerjaschki; A Mooney; W G Couser; K M Koch
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

4.  Role of extracellular matrix and Ras in regulation of glomerular epithelial cell proliferation.

Authors:  A V Cybulsky; A J McTavish; J Papillon; T Takano
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

5.  Secreted protein acidic and rich in cysteine deficiency ameliorates renal inflammation and fibrosis in angiotensin hypertension.

Authors:  Matthew J Socha; Marlina Manhiani; Neveen Said; John D Imig; Kouros Motamed
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

6.  SPARC is expressed by mesangial cells in experimental mesangial proliferative nephritis and inhibits platelet-derived-growth-factor-medicated mesangial cell proliferation in vitro.

Authors:  R H Pichler; J A Bassuk; C Hugo; M J Reed; E Eng; K L Gordon; J Pippin; C E Alpers; W G Couser; E H Sage; R J Johnson
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

7.  Expression of platelet-derived growth factor receptors in normal and diseased human kidney. An immunohistochemistry and in situ hybridization study.

Authors:  L Gesualdo; S Di Paolo; S Milani; M Pinzani; C Grappone; E Ranieri; G Pannarale; F P Schena
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

8.  Extracellular matrix modulates epidermal growth factor receptor activation in rat glomerular epithelial cells.

Authors:  A V Cybulsky; A J McTavish; M D Cyr
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

9.  DNA damage is a novel response to sublytic complement C5b-9-induced injury in podocytes.

Authors:  Jeffrey W Pippin; Raghu Durvasula; Arndt Petermann; Keiju Hiromura; William G Couser; Stuart J Shankland
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

10.  Podocyte damage is a critical step in the development of glomerulosclerosis in the uninephrectomised-desoxycorticosterone hypertensive rat.

Authors:  M Kretzler; I Koeppen-Hagemann; W Kriz
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.